Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00135447 · ClinicalTrials.gov registry record
A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen
A clinical trial, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 5,000
- Enrollment target
NCT00135447: Completed study, sponsored by Bristol-Myers Squibb.
NCT00135447 is a clinical trial that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 5,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00135447 has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 5,000 participants
- Enrollment target
Study Summary
The purpose of this study is to find out the frequency of the I50L substitution among patients experiencing treatment failure on an atazanavir-containing regimen.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2004-09 |
| Est. Completion | 2009-09 |
What the finished NCT00135447 record still lists
NCT00135447 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00135447 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00135447 about?
NCT00135447 is a clinical study titled "A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen". The purpose of this study is to find out the frequency of the I50L substitution among patients experiencing treatment failure on an atazanavir-containing regimen.
What is the current status of trial NCT00135447?
This trial is currently completed. The enrollment target is 5,000 participants. The study started on 2004-09. Estimated completion is 2009-09.
Who is sponsoring clinical trial NCT00135447?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia